# A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

> **NCT05914805** · PHASE3 · COMPLETED · sponsor: **Cassiopea SpA** · enrollment: 762 (actual)

## Conditions studied

- Alopecia, Androgenetic

## Interventions

- **DRUG:** Clascoterone 5% solution
- **DRUG:** Vehicle solution

## Key facts

- **NCT ID:** NCT05914805
- **Lead sponsor:** Cassiopea SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-17
- **Primary completion:** 2025-07-16
- **Final completion:** 2025-07-16
- **Target enrollment:** 762 (ACTUAL)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05914805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05914805, "A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05914805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*